| Stock-based compensation for awards detailing where recorded in Statement of Operations |
| |
|
|
|
|
|
|
|
|
|
|
|
Three months ended April 30, |
|
Nine months ended April 30, |
|
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Cost of sales |
|
$ 88,000 |
|
159,000 |
|
361,000 |
|
466,000 |
|
Selling, general and administrative expenses |
|
824,000 |
|
1,827,000 |
|
2,875,000 |
|
4,301,000 |
|
Research and development expenses |
|
206,000 |
|
346,000 |
|
741,000 |
|
991,000 |
|
Stock-based compensation expense before income tax benefit |
|
1,118,000 |
|
2,332,000 |
|
3,977,000 |
|
5,758,000 |
|
Income tax benefit |
|
(399,000) |
|
(839,000) |
|
(1,430,000) |
|
(2,134,000) |
|
Net stock-based compensation expense |
|
$ 719,000 |
|
1,493,000 |
|
2,547,000 |
|
3,624,000 | |
| Actual income tax benefit recognized for tax deductions relating to the exercise of stock-based awards |
| |
|
|
|
|
|
|
|
Nine months ended April 30, |
|
|
|
2011 |
|
2010 |
|
|
|
|
|
|
|
Actual income tax benefit recorded for the tax deductions relating to the exercise of stock-based awards |
|
$ 291,000 |
|
$ 472,000 |
|
Less: Tax benefit initially recognized on exercised stock-based awards vesting subsequent to the adoption of accounting standards that require us to expense stock-based awards |
|
(137,000) |
|
(213,000) |
|
Excess income tax benefit recorded as an increase to additional paid-in capital |
|
154,000 |
|
259,000 |
|
Less: Tax benefit initially disclosed but not previously recognized on exercised equity-classified stock-based awards vesting prior to the adoption of accounting standards that require us to expense stock-based awards |
|
- |
|
(7,000) |
|
Excess income tax benefit from exercised equity-classified stock-based awards reported as a cash flow from financing activities in our Condensed Consolidated Statements of Cash Flows |
|
$ 154,000 |
|
$ 252,000 | |